• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

D-4F,一种载脂蛋白 A-I 模拟肽,通过三磷酸腺苷结合盒转运体 A1 促进巨噬细胞胆固醇外流。

D-4F, an apolipoprotein A-I mimetic peptide, promotes cholesterol efflux from macrophages via ATP-binding cassette transporter A1.

机构信息

Department of Cardiology, The Second Xiang Ya Hospital of Central South University, Changsha, Hunan, PR.

出版信息

Tohoku J Exp Med. 2010 Mar;220(3):223-8. doi: 10.1620/tjem.220.223.

DOI:10.1620/tjem.220.223
PMID:20208418
Abstract

Cholesterol efflux is the key step of reverse cholesterol transport and has become a therapeutic target against atherosclerosis. Human apolipoprotein A-I (apoA-I) is the main protein in high-density lipoprotein (HDL) and has 243 amino acids. ApoA-I mimetic peptides have no sequence homology to apoA-I but possess the class-A amphipathic helical motif that presents in apoA-I lipid binding domains. D-4F is one of the apoA-I mimetic peptides and exerts diverse atheroprotective functions similar to apoA-I. However, the exact role of D-4F on lipid metabolism in macrophages is not clear yet. Therefore, we studied the effect of D-4F on cholesterol efflux, cAMP levels and expression of ATP-binding cassette transporter A1 (ABCA1) in RAW264.7 mouse macrophages. Cells were incubated with 1, 10, 50 or 100 microg/ml D-4F for 24 hours, and the cholesterol efflux was assessed. Here, D-4F significantly increased the cholesterol efflux in concentration- and time-dependent manners. Concomitantly, D-4F increased intracellular cAMP levels and the expression levels of ABCA1 mRNA and protein in a dose-dependent manner, consistent with the increase in the cholesterol efflux from macrophages. 8-Br-cAMP (cAMP activator) increased the D-4F-mediated cholesterol efflux by 39%. Moreover, the increases in cholesterol efflux and ABCA1 expression induced by 8-Br-cAMP could be inhibited by the treatment with H89, a protein kinase A (PKA) inhibitor. In conclusion, these results suggest that the synthetic peptide D-4F promotes cholesterol efflux in macrophages through the cAMP-PKA-ABCA1 pathway, which may open new avenues for the treatment of atherosclerosis.

摘要

胆固醇外排是胆固醇逆转运的关键步骤,已成为抗动脉粥样硬化的治疗靶点。人载脂蛋白 A-I(apoA-I)是高密度脂蛋白(HDL)中的主要蛋白,含有 243 个氨基酸。apoA-I 模拟肽与 apoA-I 没有序列同源性,但具有存在于 apoA-I 脂质结合域中的 A 类两亲性螺旋基序。D-4F 是 apoA-I 模拟肽之一,具有与 apoA-I 相似的多种抗动脉粥样硬化功能。然而,D-4F 对巨噬细胞中脂质代谢的确切作用尚不清楚。因此,我们研究了 D-4F 对 RAW264.7 小鼠巨噬细胞胆固醇外排、cAMP 水平和 ATP 结合盒转运体 A1(ABCA1)表达的影响。细胞用 1、10、50 或 100μg/ml D-4F 孵育 24 小时,评估胆固醇外排。结果表明,D-4F 以浓度和时间依赖的方式显著增加胆固醇外排。同时,D-4F 以剂量依赖的方式增加细胞内 cAMP 水平和 ABCA1 mRNA 和蛋白的表达水平,与巨噬细胞中胆固醇外排的增加一致。8-Br-cAMP(cAMP 激活剂)增加了 39%的 D-4F 介导的胆固醇外排。此外,8-Br-cAMP 诱导的胆固醇外排和 ABCA1 表达的增加可被蛋白激酶 A(PKA)抑制剂 H89 抑制。总之,这些结果表明,合成肽 D-4F 通过 cAMP-PKA-ABCA1 途径促进巨噬细胞中的胆固醇外排,这可能为动脉粥样硬化的治疗开辟新途径。

相似文献

1
D-4F, an apolipoprotein A-I mimetic peptide, promotes cholesterol efflux from macrophages via ATP-binding cassette transporter A1.D-4F,一种载脂蛋白 A-I 模拟肽,通过三磷酸腺苷结合盒转运体 A1 促进巨噬细胞胆固醇外流。
Tohoku J Exp Med. 2010 Mar;220(3):223-8. doi: 10.1620/tjem.220.223.
2
[Effect of apolipoprotein A-I mimetic peptides on cholesterol efflux in RAW264.7 cells].[载脂蛋白A-I模拟肽对RAW264.7细胞胆固醇流出的影响]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Jan;36(1):51-7. doi: 10.3969/j.issn.1672-7347.2011.01.008.
3
Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI.载脂蛋白A-I而非高密度脂蛋白被RAW巨噬细胞内化:ATP结合盒转运蛋白A1和清道夫受体BI的作用。
J Mol Med (Berl). 2008 Feb;86(2):171-83. doi: 10.1007/s00109-007-0267-1. Epub 2007 Oct 1.
4
The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1.载脂蛋白A-I螺旋10在载脂蛋白通过ATP结合盒转运蛋白ABCA1介导的胆固醇流出中的作用。
J Biol Chem. 2002 Oct 18;277(42):39477-84. doi: 10.1074/jbc.M207005200. Epub 2002 Aug 13.
5
cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts.环磷酸腺苷(cAMP)诱导ATP结合盒转运体A1(ABCA1)磷酸化活性,并促进成纤维细胞中的胆固醇外流。
J Lipid Res. 2002 Dec;43(12):2087-94. doi: 10.1194/jlr.m200235-jlr200.
6
The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo.载脂蛋白A-I的中央螺旋可促进ATP结合盒转运蛋白A1(ABCA1)介导的脂质流出。野生型载脂蛋白A-I的氨基酸残基220-231是体外脂质流出和体内高密度脂蛋白形成所必需的。
J Biol Chem. 2003 Feb 28;278(9):6719-30. doi: 10.1074/jbc.M205232200. Epub 2002 Dec 17.
7
Contribution of D4-F to ABCA1 expression and cholesterol efflux in THP-1 macrophage-derived foam cells.D4-F 对 THP-1 巨噬细胞源性泡沫细胞中 ABCA1 表达和胆固醇外流的贡献。
J Cardiovasc Pharmacol. 2010 Sep;56(3):309-19. doi: 10.1097/FJC.0b013e3181edaf69.
8
Study of ATP-binding cassette transporter A1 (ABCA1)-mediated cellular cholesterol efflux in diabetic golden hamsters.糖尿病金黄仓鼠中ATP结合盒转运蛋白A1(ABCA1)介导的细胞胆固醇流出的研究
J Int Med Res. 2007 Jul-Aug;35(4):508-16. doi: 10.1177/147323000703500410.
9
Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter.载脂蛋白A-I通过ABCA1转运蛋白激活细胞cAMP信号传导。
J Biol Chem. 2004 Mar 12;279(11):9963-9. doi: 10.1074/jbc.M313487200. Epub 2003 Dec 29.
10
Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein.人糜蛋白酶导致前β-高密度脂蛋白耗竭会损害ATP结合盒转运蛋白A1介导的脂质外流至高密度脂蛋白,但不会损害I型清道夫受体介导的脂质外流。
J Biol Chem. 2004 Mar 12;279(11):9930-6. doi: 10.1074/jbc.M312476200. Epub 2003 Dec 29.

引用本文的文献

1
Recombinant high-density lipoprotein targeted delivery of celastrol to promote foam cells lipophagy against early atherosclerosis.重组高密度脂蛋白靶向递送雷公藤红素以促进泡沫细胞自噬对抗早期动脉粥样硬化。
J Nanobiotechnology. 2025 Mar 22;23(1):237. doi: 10.1186/s12951-025-03327-9.
2
Emerging Therapeutic Targets for Acute Coronary Syndromes: Novel Advancements and Future Directions.急性冠状动脉综合征的新兴治疗靶点:新进展与未来方向
Biomedicines. 2024 Jul 26;12(8):1670. doi: 10.3390/biomedicines12081670.
3
Apolipoproteins as potential communicators play an essential role in the pathogenesis and treatment of early atherosclerosis.
载脂蛋白作为潜在的通讯者,在早期动脉粥样硬化的发病机制和治疗中发挥着重要作用。
Int J Biol Sci. 2023 Aug 21;19(14):4493-4510. doi: 10.7150/ijbs.86475. eCollection 2023.
4
Post-Stroke Administration of L-4F Promotes Neurovascular and White Matter Remodeling in Type-2 Diabetic Stroke Mice.中风后给予L-4F可促进2型糖尿病中风小鼠的神经血管和白质重塑。
Front Neurol. 2022 Apr 28;13:863934. doi: 10.3389/fneur.2022.863934. eCollection 2022.
5
D-4F, an apolipoprotein A-I mimetic, promotes the clearance of myelin debris and the reduction of foamy macrophages after spinal cord injury.D-4F,一种载脂蛋白 A-I 模拟物,可促进髓鞘碎片的清除和减少脊髓损伤后的泡沫巨噬细胞。
Bioengineered. 2022 May;13(5):11794-11809. doi: 10.1080/21655979.2022.2073063.
6
Remembering your A, B, C's: Alzheimer's disease and ABCA1.牢记基础知识:阿尔茨海默病与ABCA1
Acta Pharm Sin B. 2022 Mar;12(3):995-1018. doi: 10.1016/j.apsb.2022.01.011. Epub 2022 Jan 24.
7
D4F alleviates the C/EBP homologous protein-mediated apoptosis in glycated high-density lipoprotein-treated macrophages by facilitating autophagy.D4F 通过促进自噬来减轻糖基化高密度脂蛋白处理的巨噬细胞中 C/EBP 同源蛋白介导的细胞凋亡。
Exp Biol Med (Maywood). 2021 Dec;246(24):2595-2609. doi: 10.1177/15353702211045323. Epub 2021 Sep 16.
8
ApoA1 Neutralizes Proinflammatory Effects of Dengue Virus NS1 Protein and Modulates Viral Immune Evasion.载脂蛋白 A1 中和登革病毒 NS1 蛋白的促炎作用并调节病毒免疫逃避。
J Virol. 2021 Jun 10;95(13):e0197420. doi: 10.1128/JVI.01974-20.
9
Pain Control by Targeting Oxidized Phospholipids: Functions, Mechanisms, Perspectives.靶向氧化磷脂的疼痛控制:功能、机制与展望。
Front Endocrinol (Lausanne). 2021 Jan 25;11:613868. doi: 10.3389/fendo.2020.613868. eCollection 2020.
10
A novel apoA-I mimetic peptide suppresses atherosclerosis by promoting physiological HDL function in apoE mice.一种新型载脂蛋白A-I模拟肽通过促进载脂蛋白E基因敲除小鼠体内生理性高密度脂蛋白功能来抑制动脉粥样硬化。
Br J Pharmacol. 2020 Oct;177(20):4627-4644. doi: 10.1111/bph.15213. Epub 2020 Sep 9.